http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015020971-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_83a8aa00711befe145556dba4e57ec5a |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
filingDate | 2013-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b0529333d6e0c19c584952fc88e9b32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_976136e009f7a0a086984a43167e559b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6503c9d44672b706ba95718f7d0dcebe |
publicationDate | 2015-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2015020971-A |
titleOfInvention | Clarithromycin gastric suspension |
abstract | Disclosed is a gastric buoyant preparation of clarithromycin without using a special additive or the like. According to the present invention, there is provided a gastric suspension preparation comprising clarithromycin crystal form 0 or clarithromycin crystal form I and a pharmaceutically acceptable carrier. The gastric buoyant preparation of the present invention comprises the steps of mixing clarithromycin crystal form 0 or clarithromycin crystal form I and a pharmaceutically acceptable carrier, and molding the resulting mixture under pressure. It can manufacture by the method of including. [Selection figure] None |
priorityDate | 2013-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.